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Summary Adrenal insufficiency associated with cytomegalovirus (CMV) is a well-described
condition in adults with AIDS, however there is little information about CMV-associated adrenal
insufficiency in childhood. The cases of two infants with negative HIV serology, presenting with
CMV-associated adrenal insufficiency, are described. Clinical findings and therapeutic interven-
tions are discussed with reference to the affinity of CMV infection for the adrenal gland. The
differential diagnosis of adrenal insufficiency in newborns and infants should include CMV
infection, and clinical suspicion of CMV-associated adrenal insufficiency should lead to early
initiation of appropriate adrenal substitution therapy and ganciclovir antiviral therapy. Timely
therapy for CMV-associated adrenal insufficiency can be lifesaving.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Cytomegalovirus (CMV) is the most common congenital viral
infection in humans, occurring in 0.4—2.3% of all live births.1
Transmission of CMVmaybe transplacental or via saliva, sexual
contact, breastfeeding, blood transfusion, or transplanta-
tion.2 At birth, 7—10% of congenitally infected infants display
severe symptoms associated with cholestatic liver disease,
encephalitis, coagulation disorders, thrombocytopenia, or
pneumonitis.3 Although CMV-associated adrenal failure is a
well-described condition in adults with AIDS, there is little
information related to its incidence in childhood.4—9 The
pathogenesis of CMV-associated adrenal failure remains poorly
understood, but immune processes may play a role.* Corresponding author. Tel./fax: +90 222 2290064.
E-mail address: timboothtr@yahoo.com (E.C. Dinleyici).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.08.021Wedescribe herein the cases of two infants presenting with
CMV-associated adrenal insufficiency, and discuss the affinity
of CMV infection for the adrenal gland, the associated clinical
and laboratory findings, and therapeutic interventions.
Case reports
Patient 1
A 28-day-old girl was referred to our hospital with acute
diarrhea, vomiting, and fever. She was born to a 21-year-old
mother at 40 weeks of gestation (birth weight 2600 g) and
had been hospitalized following birth for 6 days due to
meconium aspiration. On admission, she was a formula-fed
infant, weighing 2765 g (<5th percentile), with a height of
46 cm (<5th percentile) and a head circumference of 35 cm
(between normal limits). Physical examination revealed aPublished by Elsevier Ltd. All rights reserved.
Table 1 Clinical and laboratory characteristics of the two patients.
Patient 1 Patient 2
At admission After ganciclovir
therapy
6 months
later
At admission After ganciclovir
therapy
6 months
later
Na (mEq/l) 117 132 144 117 138 142
K (mEq/l) 6.8 4.3 5.3 6.3 4.73 5.18
Cl (mEq/l) 93 100 109 93 99 97
Glucose (mg/dl) 68 57 75 106 78 72
Cortisol (mg/dl) 3.98 9.57 1.41 9.9
ACTH (pg/ml) 118.6 16.6 68 15
AST (IU/l) 219 131 44 70 39
ALT (IU/l) 279 96 41 54 20
Total/direct bilirubin 0.68/0.13 0.7/0.1 3.9/3.7 0.68/0.27 0.2/0.1
Anti-CMV IgM (IU/ml) 2.8 - 1.7 3.84 0.6
Anti-CMV IgG (IU/ml) 35 - 30 22 12
IgG avidity Low - High Low High
CMV-DNA
(genome copies/ml)
179 003 - 1542 207 360 223
Immunological
evaluation
Serum IgG, IgA,
IgM normal,
Th/Ts: 0.3
(0.6—2.8),
CD4% 19.5%
(30—60%)
Th/Ts: 0.9
(0.6—2.8),
CD4% 31.7%
(30—60%)
Normal - -
Audiological evaluation - - Bilateral SNHL - - Normal
ACTH, adrenocorticotropic hormone; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CMV, cytomegalovirus; Th/Ts, T
helper cell/suppressor cell ratio; SNHL, sensorineural hearing loss.
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pressure 70/50 mmHg, heart rate 140/min, respiratory rate
44/min, and blood oxygen saturation 98% on room air. Hepa-
tomegaly, palpable at 3 cm below the costal margin, and
splenomegaly, palpable at 2 cm, were noted. No rashes were
present and the ophthalmologic examination was normal.
The patient’s white blood cell count was 22.8  109/l with
68% lymphocytes, liver function tests were mildly elevated
(Table 1), and serologic tests were negative for viral hepatitis
and rubella. Electrocardiogram and echocardiogram were
normal, chest X-ray showed diffuse interstitial infiltrates,
and cranial computed tomography (CT) showed radiological
findings associated with encephalitis but no calcification.
Microscopic and laboratory examinations of cerebrospinal
fluid (CSF) were normal except formild lymphocytosis. Urine,
CSF, and blood cultures were negative for bacterial growth.
The anti-CMV IgM antibody index was 2.8 IU/ml (0.7—0.9 IU/
ml), IgG antibody level was 35 UI/ml (4—6 IU/ml), anti-CMV
IgG avidity was 10% (low avidity,<35%), and quantitative CMV
viral load in blood showed significant viremia (179 003 gen-
ome copies/ml). Maternal serum was negative for anti-CMV
IgM, but positive for anti-CMV IgG. There was no prenatal
maternal CMV serology and breast milk was not tested due to
lack of breastfeeding. Serum total IgG and IgA were within
normal limits. T lymphocyte subsets showed decreased CD4+
Tcells and T helper cell/suppressor cell (Th/Ts) ratio, with a
normal percentage of CD8+ Tcells (Table 1). Serologic testing
for HIV was negative on admission and at 6-month follow-up.
Six hours after admission, the patient experienced sudden
onset of lethargy, hypotension (35/17 mmHg), and hypogly-
cemia (22 mg/dl). Laboratory findings included an increase inserum potassium to 7.4 mEq/l, a decrease in serum sodium to
116 mEq/l, and elevated adrenocorticotropic hormone
(ACTH). The constellation of low serum sodium and cortisol
with increased serum potassium and ACTH, in conjunction
with vomiting, diarrhea, and hypotension, was suggestive of
adrenal insufficiency. Abdominal ultrasonography showed
bilateral adrenal hypoplasia. The patient was treated with
intensive fluid replacement, cortisone and mineralocorticoid
substitution, and 10 mg/kg ganciclovir. On day 6 of treat-
ment, serum electrolytes had returned to normal and enteral
feeding was begun. After completion of ganciclovir treat-
ment, the steroid dosage was tapered over the course of 1
month and discontinued. At the 6-month follow-up visit,
serum electrolytes, cortisol, ACTH levels, and blood pressure
were normal, aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) were slightly increased, anti-CMV IgM
had decreased to 1.7 IU/ml, and anti-CMV IgG remained high
(30 IU/ml). The patient’s growth and neurological milestones
were age-appropriate, but bilateral sensorineural hearing
loss (SNHL) was observed on BERA examination (brainstem
evoked response audiometry). T lymphocyte subsets were
within normal limits.
Patient 2
A 59-day-old boy was admitted to our clinic with lethargy,
poor feeding, vomiting, and jaundice for 1 week prior to
admission. He had been delivered by cesarean section at 39
weeks of gestation to a 26-year-old woman. On admission, his
body temperature was 36.2 8C, heart rate was 170/min,
respiratory rate was 40/min, and blood pressure was 45/
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galy, the liver edge measuring 4 cm below the right costal
margin. Length, height, and head circumference were age-
appropriate.
Laboratory examination revealed anemia, lymphocytosis,
and elevated erythrocyte sedimentation rate and serum C-
reactive protein levels (Table 1). Serum sodiumwas 117 mEq/
l, potassium 6.3 mEq/l, chloride 93 mEq/l, cortisol 1.41 mg/
dl, ACTH 68 pg/ml, and triglycerides 274 mg/dl. Bilirubin was
elevated at 3.7 mg/dl (total/indirect). Cefepime and ami-
kacin were started due to a suspicion of sepsis. The con-
stellation of vomiting and hypotension, decreased sodium,
chloride, and cortisol, and increased potassium and ACTH
was suggestive of adrenal insufficiency. The patient was
treated with intensive fluid replacement, as well as cortisone
and ACTH substitution. The anti-CMV IgM antibody index
value of the patient was 3.84 (0.7—0.9 IU/ml), IgG was 22
IU/ml (4—6) with low IgG avidity, and quantitative CMV viral
load in blood showed significant viremia (207 360 genome
copies/ml) (Table 1). Maternal serum was negative for anti-
CMV IgM antibody but positive for anti-CMV IgG. Ganciclovir
therapy was added to the steroid therapy. Blood cultures
were negative. Serology was negative for rubella, hepatitis,
and HIV on admission and for HIV at 6-month follow-up. No
chorioretinitis was observed on ophthalmologic examination.
Adrenal glands were normal on sonographic examination. By
day 5 of ganciclovir and steroid therapy, serum electrolytes
and blood pressure had returned to normal. After completion
of the ganciclovir treatment, steroids were tapered and
discontinued. At the 6-month follow-up visit, serum electro-
lytes, cortisol, ACTH levels, and blood pressure levels were
normal. Anti-CMV IgM levels had decreased to 0.6 IU/ml and
anti-CMV IgG remained high (12 IU). The patient’s growth,
neurological milestones, and hearing screen were normal. T
lymphocyte subsets were within normal limits. Abdominal
magnetic resonance imaging (MRI) showed bilateral adrenal
hypoplasia.
Discussion
Patients with CMV infection may have complications of adre-
nalitis or adrenal insufficiency, which can delay diagnosis.
Although CMV can affect many organs, it has a particular
affinity for the adrenal gland; the adrenal glands are affected
by CMV in 93% of CMV-infected patients with AIDS.5 Func-
tional impairment of the adrenal glands develops insidiously
and is often not diagnosed before the development of overt,
life-threatening adrenal insufficiency. In addition to clinical
symptoms, the patients presented in this report had low
serum sodium, chloride, and basal cortisol, and high serum
potassium and ACTH. Both patients responded well to ster-
oids and ganciclovir; 6 months after discontinuation of ster-
oid therapy, their clinical and laboratory findings were
normal. Clinical findings of adrenal insufficiency associated
with congenital and perinatal CMV infection have not been
previously reported in the literature. Hsu et al.10 did report a
premature infant with perinatal CMV infection and postmor-
tem histopathological findings of adrenalitis without clinical
and laboratory features of adrenal failure. They concluded
that the functional status of the adrenal glands should be
followed closely in CMV-infected premature newborns who
have unexplained electrolyte imbalances, fever, diarrhea,weight loss, or hypotension. In our patients, serological
testing for HIV infection was negative at presentation and
at 6-month follow-up. A transient decrease of CD4 cells and a
diminished Th/Ts ratio were observed in the first case. The
maturity of a patient’s immune response appears to be a
major factor in combating viral infection.2 Immaturity of the
immune response or a transient immune deficiency state may
be associated with a more severe clinical course.
The histopathologic characteristics of CMV adrenalitis
vary considerably, ranging from involvement of a few cells
to large areas of extensive coagulation necrosis.4 The patho-
genesis of the distinct tropism of the adrenal gland by CMV
remains unknown.4 Marik et al.11 have suggested that CMV
infection reduces adrenal reserves and predisposes patients
to adrenal insufficiency. Adrenalitis due to CMV infection is a
common postmortem finding in patients with AIDS and can
result in hypoadrenalism in vivo.6 Hypoadrenalism may be
underestimated in congenitally or perinatally infected
patients. Ultrasonographic examination of the first patient
showed bilateral adrenal hypoplasia. The first ultrasono-
graphic examination of our second patient was normal,
except for hepatomegaly, but 1 month later, abdominal
MRI also showed bilateral adrenal hypoplasia. Bale et al.12
reported hypoplasia of the adrenal glands on autopsy of a
premature infant with CMV infection, although human CMV
nucleic acid was not detected in the adrenal tissue.
Clinical manifestations of adrenal insufficiency are often
not apparent until 90% of the gland has been destroyed. On
retrospective evaluation of our clinical data, we had not
diagnosed adrenal failure in our other patients with CMV
infection, but routine screening for cortisol and ACTH levels
had not been performed for all patients with disseminated
CMV disease. We diagnosed and monitored CMV infection on
the basis of clinical signs in the presence of anti-CMV IgM, low
avidity IgG, and CMV viral load in blood.
Since the first patient presented with symptoms in the first
3 weeks of life, CMV infection was most likely congenital. The
second patient could have been infected perinatally since
perinatal infections in otherwise healthy infants usually
manifest between 4 and 16 weeks of age. It is difficult to
make a definitive distinction — like with these patients —
between congenital and perinatally acquired infection in
infants past 3 weeks of age unless one is able to evaluate
dried blood spots (e.g., a Guthrie card) or a urine sample
acquired in the first 3 weeks of life. The first patient was a
formula-fed infant who had not been exposed to breast milk;
her mother was not able to provide breast milk for evalua-
tion. The second case had been breastfed for the first month,
however, on admission, themother had nomilk for evaluation
and the baby was formula-fed. The first patient had bilateral
SNHL despite ganciclovir treatment. Neurological examina-
tion and developmental milestones were normal at the fol-
low-up visit. Bilateral SNHL supported the possibility that
CMV infection was acquired by intrauterine virus transmis-
sion. Generally, perinatally acquired CMV infections do not
seem to cause neurodevelopmental sequelae or deafness. A
hearing screen of the second patient was normal; however, it
is difficult to distinguish congenital from perinatal CMV
infection in this patient because he was treated promptly
with ganciclovir therapy.
The distinction between perinatal and congenital CMV
infection is important for long term prognosis. However, this
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ment in patients with adrenal failure or other systemic
features of disseminated disease. Adrenal biopsy is not prac-
tical in children with adrenal failure, and viral culture is not
routinely carried out and requires at least 21 days to be
reported, although it can be useful for resistance testing. The
goal of the treatment of infected newborns is to diminish the
development of life-threatening disease and severe organ
damage. In severe life-threatening infection of a newborn,
therapy with ganciclovir and intravenous immunoglobulin is
undoubtedly indicated,3 although CMV-induced hypoadren-
alism in patients with AIDS is rarely reversible after ganci-
clovir treatment.7,9 We used ganciclovir for both patients and
did not observe any side effects. The substitutive hormone
therapy was continued during ganciclovir therapy, and was
tapered within 1 month for both patients. At 6 months, the
patients had no clinical or laboratory abnormalities, although
both patients had radiological findings of hypoadrenalism.
For this reason, we suggest that patients with adrenal failure
associated with CMV infection should undergo long-term
follow-up and evaluation of adrenal function.
Several congenital and perinatally acquired causes of adre-
nal failure during infancy were considered in our patients, and
were excluded by clinical history and diagnostic testing. In
contrast to patients with congenital adrenal hyperplasia,
presenting patients did not require steroid therapy beyond
the acute phase. Deletion analysis for theNROB1 gene on the X
chromosomewas not performed to rule out congenital adrenal
hypoplasia; however, both patients responded well to steroids
and ganciclovir. Other excludedcauses of adrenal insufficiency
were adrenal hemorrhage, tuberculosis, HIV infection, hemo-
chromatosis, and metabolic disorders that include Wolman
disease and Smith—Lemli—Opitz syndrome (SLOS). SLOS was
excluded by normal serum cholesterol. For these presenting
cases, the transient nature of the adrenal failure, treated
successfully with steroids and ganciclovir, was suggestive of
adrenal failure caused by CMV infection.
The direct or indirect pathogenetic role of CMV in organ
involvement remains poorly understood. Bissinger et al.13
have reported that the lungs, pancreas, kidneys, and liver are
the major target organs, with a high number of CMV-infected
cells. According to this report, the adrenal glands are the
sixth most commonly infected major organs with CMV.13
Although definitive proof is lacking, generalized CMV infec-
tion is the most likely cause of our patients’ symptoms of
adrenal failure. The differential diagnosis of adrenal insuffi-
ciency during the newborn period and infancy must include
CMV infection in patients with or without AIDS. Clinicalsuspicion with early initiation of appropriate substitution
therapy, including steroids and ganciclovir, could be lifesav-
ing in patients with adrenal insufficiency associated with CMV
infection.
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